Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01291719 · ClinicalTrials.gov registry record · Phase 1
Insulin Balanced Infusion System
A Phase 1 study of Diabetes and Hyperglycemia, sponsored by Admetsys Corporation.
- Active
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01291719: Active Phase 1 study of Diabetes and Hyperglycemia, sponsored by Admetsys Corporation.
NCT01291719 is a Phase 1 study of Diabetes and Hyperglycemia that is active but no longer recruiting, run by Admetsys Corporation. The registered enrollment target is 40 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01291719, a Phase 1 study of Diabetes and Hyperglycemia, is active but no longer recruiting, sponsored by Admetsys Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to study the use of a counterbalancing system of glucose and insulin infusion with frequent blood glucose monitoring and combined adaptive algorithm can produce tight glycemic control without hypoglycemia; study to develop a closed loop for use in intensive care units and surgery
Primary Outcome
blood glucose measurements in target range (80-125 mg/dl)
Conditions Studied
Interventions
- DEVICE glucose and insulin infusions
Study Locations (1)
Florida
- 3113 Lawton Road - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-11 |
| Est. Completion | 2026-11 |
| Phase | Phase 1 |
What the registry record for NCT01291719 still lists
NCT01291719 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which glucose and insulin infusions is the first listed.
NCT01291719 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01291719 about?
NCT01291719 is a clinical study titled "Insulin Balanced Infusion System". The purpose of this study is to study the use of a counterbalancing system of glucose and insulin infusion with frequent blood glucose monitoring and combined adaptive algorithm can produce tight glycemic control without hypoglycemia; study to develop a closed loop for use in intensive care units an...
What is the current status of trial NCT01291719?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2008-11. Estimated completion is 2026-11.
What conditions does trial NCT01291719 study?
This clinical trial studies the following conditions: Diabetes, Hyperglycemia.
What interventions are being tested in trial NCT01291719?
The interventions under investigation include: glucose and insulin infusions (DEVICE).
Who is sponsoring clinical trial NCT01291719?
This trial is sponsored by Admetsys Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01291719 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01291719's enrollment target sits among peer trials
40 263rd of 338 higher than 70 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mitigating the Pro-inflammatory Phenotype of Obesity
RECRUITING · Phase 1
-
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
RECRUITING · Phase 1
-
Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption
COMPLETED · Phase 1
-
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
COMPLETED · Phase 1
-
Family Management of Childhood Diabetes Study
COMPLETED · Phase 1
-
Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia